DANAHER CORPORATION Inactive Instrument
Danaher Corporation Share Price Nyse
Equities
DHR PRA
US2358513008
Advanced Medical Equipment & Technology
| Sales 2024 * | 2.39TCr 1,99400Cr | Sales 2025 * | 2.6TCr 2,17000Cr | Capitalization | 19TCr 16,27100Cr |
|---|---|---|---|---|---|
| Net income 2024 * | 441.7Cr 37TCr | Net income 2025 * | 536.5Cr 45TCr | EV / Sales 2024 * | 8.52 x |
| Net Debt 2024 * | 853.62Cr 71TCr | Net Debt 2025 * | 269.57Cr 23TCr | EV / Sales 2025 * | 7.6 x |
| P/E ratio 2024 * |
44.4
x | P/E ratio 2025 * |
36.5
x | Employees | 62,000 |
| Yield 2024 * |
0.41% | Yield 2025 * |
0.44% | Free-Float | 74.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danaher Corporation
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 01/10/01 |
Steven Rales
FOU | Founder | 72 | 01/83/01 |
Mitchell Rales
FOU | Founder | 67 | 01/83/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 01/83/01 |
Alan Spoon
BRD | Director/Board Member | 72 | 01/99/01 |
Steven Rales
FOU | Founder | 72 | 01/83/01 |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
28/06/2024
- Détachement de
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +9.48% | 22TCr | |
| +23.79% | 15TCr | |
| +33.39% | 11TCr | |
| +4.75% | 6.65TCr | |
| +15.59% | 5.31TCr | |
| +3.16% | 5TCr | |
| -4.35% | 3.88TCr | |
| -1.27% | 3.48TCr | |
| +22.61% | 3.1TCr |
